Author Correction: Transcriptomic profiles and 5-year results from the randomized CLL14 study of venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab in chronic lymphocytic leukemia.
Saved in:
| Title: | Author Correction: Transcriptomic profiles and 5-year results from the randomized CLL14 study of venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab in chronic lymphocytic leukemia. |
|---|---|
| Authors: | Al-Sawaf O; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany. othman.al-sawaf@uk-koeln.de.; Cancer Institute, University College London, London, UK. othman.al-sawaf@uk-koeln.de.; Francis Crick Institute, London, UK. othman.al-sawaf@uk-koeln.de., Zhang C; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany., Jin HY; Genentech Inc., South San Francisco, CA, USA., Robrecht S; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany., Choi Y; Genentech Inc., South San Francisco, CA, USA., Balasubramanian S; Genentech Inc., South San Francisco, CA, USA., Kotak A; Roche Products Ltd, Welwyn Garden City, UK., Chang YM; Hoffmann-la Roche, Mississauga, ON, Canada., Fink AM; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany., Tausch E; Department III of Internal Medicine, Ulm University, Ulm, Germany., Schneider C; Department III of Internal Medicine, Ulm University, Ulm, Germany., Ritgen M; Department II of Internal Medicine, University of Schleswig Holstein, Kiel, Germany., Kreuzer KA; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany., Chyla B; AbbVie Inc., North Chicago, IL, USA., Paulson JN; Genentech Inc., South San Francisco, CA, USA., Pallasch CP; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany., Frenzel LP; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany., Peifer M; Faculty of Medicine and University Hospital Cologne, Department of Translational Genomics, University of Cologne, Cologne, Germany., Eichhorst B; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany., Stilgenbauer S; Department III of Internal Medicine, Ulm University, Ulm, Germany., Jiang Y; Genentech Inc., South San Francisco, CA, USA., Hallek M; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany. michael.hallek@uni-koeln.de., Fischer K; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany. kirsten.fischer@uk-koeln.de. |
| Source: | Nature communications [Nat Commun] 2023 Oct 23; Vol. 14 (1), pp. 6724. Date of Electronic Publication: 2023 Oct 23. |
| Publication Type: | Published Erratum |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE; PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| FullText | Links: – Type: pdflink Text: Availability: 1 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 37872229 AccessLevel: 2 PubTypeId: unknown PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Author Correction: Transcriptomic profiles and 5-year results from the randomized CLL14 study of venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab in chronic lymphocytic leukemia. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Al-Sawaf+O%22">Al-Sawaf O</searchLink>; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany. othman.al-sawaf@uk-koeln.de.; Cancer Institute, University College London, London, UK. othman.al-sawaf@uk-koeln.de.; Francis Crick Institute, London, UK. othman.al-sawaf@uk-koeln.de.<br /><searchLink fieldCode="AU" term="%22Zhang+C%22">Zhang C</searchLink>; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Jin+HY%22">Jin HY</searchLink>; Genentech Inc., South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Robrecht+S%22">Robrecht S</searchLink>; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Choi+Y%22">Choi Y</searchLink>; Genentech Inc., South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Balasubramanian+S%22">Balasubramanian S</searchLink>; Genentech Inc., South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Kotak+A%22">Kotak A</searchLink>; Roche Products Ltd, Welwyn Garden City, UK.<br /><searchLink fieldCode="AU" term="%22Chang+YM%22">Chang YM</searchLink>; Hoffmann-la Roche, Mississauga, ON, Canada.<br /><searchLink fieldCode="AU" term="%22Fink+AM%22">Fink AM</searchLink>; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Tausch+E%22">Tausch E</searchLink>; Department III of Internal Medicine, Ulm University, Ulm, Germany.<br /><searchLink fieldCode="AU" term="%22Schneider+C%22">Schneider C</searchLink>; Department III of Internal Medicine, Ulm University, Ulm, Germany.<br /><searchLink fieldCode="AU" term="%22Ritgen+M%22">Ritgen M</searchLink>; Department II of Internal Medicine, University of Schleswig Holstein, Kiel, Germany.<br /><searchLink fieldCode="AU" term="%22Kreuzer+KA%22">Kreuzer KA</searchLink>; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Chyla+B%22">Chyla B</searchLink>; AbbVie Inc., North Chicago, IL, USA.<br /><searchLink fieldCode="AU" term="%22Paulson+JN%22">Paulson JN</searchLink>; Genentech Inc., South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Pallasch+CP%22">Pallasch CP</searchLink>; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Frenzel+LP%22">Frenzel LP</searchLink>; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Peifer+M%22">Peifer M</searchLink>; Faculty of Medicine and University Hospital Cologne, Department of Translational Genomics, University of Cologne, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Eichhorst+B%22">Eichhorst B</searchLink>; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany.<br /><searchLink fieldCode="AU" term="%22Stilgenbauer+S%22">Stilgenbauer S</searchLink>; Department III of Internal Medicine, Ulm University, Ulm, Germany.<br /><searchLink fieldCode="AU" term="%22Jiang+Y%22">Jiang Y</searchLink>; Genentech Inc., South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Hallek+M%22">Hallek M</searchLink>; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany. michael.hallek@uni-koeln.de.<br /><searchLink fieldCode="AU" term="%22Fischer+K%22">Fischer K</searchLink>; Faculty of Medicine and University Hospital Cologne, Department I of Internal Medicine, Center for Integrated Oncology Aachen Bonn Cologne Duesseldorf, University of Cologne, Cologne, Germany. kirsten.fischer@uk-koeln.de. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101528555%22">Nature communications</searchLink> [Nat Commun] 2023 Oct 23; Vol. 14 (1), pp. 6724. <i>Date of Electronic Publication: </i>2023 Oct 23. – Name: TypePub Label: Publication Type Group: TypPub Data: Published Erratum – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Pub%2E+Group%22">Nature Pub. Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101528555 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2041-1723 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220411723%22">20411723 </searchLink><i>NLM ISO Abbreviation: </i>Nat Commun <i>Subsets: </i>MEDLINE; PubMed not MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37872229 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1038/s41467-023-42562-2 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 6724 Titles: – TitleFull: Author Correction: Transcriptomic profiles and 5-year results from the randomized CLL14 study of venetoclax plus obinutuzumab versus chlorambucil plus obinutuzumab in chronic lymphocytic leukemia. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Al-Sawaf O – PersonEntity: Name: NameFull: Zhang C – PersonEntity: Name: NameFull: Jin HY – PersonEntity: Name: NameFull: Robrecht S – PersonEntity: Name: NameFull: Choi Y – PersonEntity: Name: NameFull: Balasubramanian S – PersonEntity: Name: NameFull: Kotak A – PersonEntity: Name: NameFull: Chang YM – PersonEntity: Name: NameFull: Fink AM – PersonEntity: Name: NameFull: Tausch E – PersonEntity: Name: NameFull: Schneider C – PersonEntity: Name: NameFull: Ritgen M – PersonEntity: Name: NameFull: Kreuzer KA – PersonEntity: Name: NameFull: Chyla B – PersonEntity: Name: NameFull: Paulson JN – PersonEntity: Name: NameFull: Pallasch CP – PersonEntity: Name: NameFull: Frenzel LP – PersonEntity: Name: NameFull: Peifer M – PersonEntity: Name: NameFull: Eichhorst B – PersonEntity: Name: NameFull: Stilgenbauer S – PersonEntity: Name: NameFull: Jiang Y – PersonEntity: Name: NameFull: Hallek M – PersonEntity: Name: NameFull: Fischer K IsPartOfRelationships: – BibEntity: Dates: – D: 23 M: 10 Text: 2023 Oct 23 Type: published Y: 2023 Identifiers: – Type: issn-electronic Value: 2041-1723 Numbering: – Type: volume Value: 14 – Type: issue Value: 1 Titles: – TitleFull: Nature communications Type: main |
| ResultId | 1 |
